Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Acid phosphatase 5 tartrate resistant (ACP5) ELISA Kit-Sandwich

Cat. No.EK11F330

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine ACP5 ELISA Kit-Sandwich is designed for the quantitative determination of Bovine ACP5 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine ACP5.
Target Species Bovine
Species Reactivity Bovine
Recovery 97%-105%
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 180 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids;10 μL

Target Information

Acid phosphatase 5 tartrate resistant is encoded by the ACP5 gene in cattle. It is a metalloenzyme that is characteristic for its expression in activated osteoclasts and in macrophages.

Target/Biomarker Bovine ACP5
Target Synonym acid phosphatase 5 tartrate resistant; TRAP; tartrate-resistant acid phosphatase type 5; acid phosphatase type 5; tartrate-resistant acid phosphatase; uteroferrin
Gene ID 517002

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Reithmeier, A. et al. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells. BMC Cancer. 2017, 17: 650.
Inquiry Basket